Genomics in Drug Discovery and Development (Training Workshop)




Explore how genomics information and data collection is driving change within drug development. This training workshop is aimed at early career pre-clinical scientists and early career clinical development professionals.


Find out more and register

This online training workshop will explore how genomics information and data collection is driving change within drug development. This training course is aimed at early career pre-clinical scientists and early career clinical development professionals and will help them understand the relevance of genomics within the drug development process.

Learning Outcomes:
1. How targeted approaches and applications in early drug discovery are changing because of genomic data
2. The continued growth of bioinformation and managing big data
3. Understanding the role of consent forms and considerations for a fuller data collection from patients
4. The importance of diagnostics and the need for better markers within in clinic

If you have any questions, please do not hesititate to contact the Education team (education@bps.ac.uk / +44 20 7239 0170).

Find out more and register

View and download a copy of the programme as a PDF here

10:00 - 10:15 Welcome and plan for the day
Caroline Haefliger - Head of Translational Medicine, Debiopharm

10:15 - 10:45 Genomics sample collections - ethics and consent
Helen Stevens - Principal Scientist, Centre for Genomics Researchm AstraZeneca

10:45 - 11:15 Towards two million genomes - overcoming challenges of data volume
Sebastian Wasilewski - Senior Director of Genome Informatics, AstraZeneca

11:15 - 11:45 How genetic information is transforming drug discovery
Charles Cox - Head of Pharmacogenetics, GlaxoSmithKline

11:45 - 12:00 Break

12:00 - 12:30 Precision medicine in the clinic

Caroline Haefliger - Head of Translational Medicine, Debiopharm

12:30 - 13:00 Breakout session 1

13:00 - 13:40 Lunch

13:40 - 14:10 Breakout session 2

14:10 - 14:40 UK Biobank sequencing data informs target identification

Karen Carss - Director if Genome Analytics, AstraZeneca

14:40 - 15:10 Breakout session 3

15:10 - 15:25 Break

15:25 - 15:55 The Industry Pharmacogenomics Working Group (I-PWG) - Overcoming challenges in pharmacogenomics together

Julian Arbuckle - Director of the Industry Pharmacogenomics Working Group (I-PWG)

15:55 - 16:25 Breakout session 4

16:25 - 16:30 Summary and revisit Learning Outcomes

Caroline Haefliger - Head of Translational Medicine, Debiopharm
From
23 March 2023
To
23 March 2023
Time
10 am GMT to 4 30 pm GMT
Venue
Online



Connect with us:

© 2021 British Pharmacological Society, The Schild Plot, 16 Angel Gate, City Road, London EC1V 2PT, United Kingdom

loading